Conference Information

Welcome Message

On behalf of the organizing committee, we are pleased to stretch out our greetings to welcome all members from a worldwide reach to join our "11th International Conference on Neurodegenerative Disorders and Stroke" scheduled from April 25, 2022 as Webinar which will involve vivacious discussions, brief feature introductions, Oral discussions, banner introductions, E-Poster displays and organizing openings around a center of entire and simultaneous meetings dependent on significant issues in the area of Neurodegenerative Disorders and Stroke. This is a magnificence highest point including medical services experts, academicians, understudies, and analysts around the world to connect and expand their knowledge globally.

Stroke 2022 has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Committee.

Stroke 2022 is our eleventh most recent expansion to our gatherings in the field of neurodegenerative problems and Stroke. We center around perceiving individuals in the different examination field who are accomplishing dumbfounding exploration work in Neurodegenerative disorders and Stroke that would be gainful for all the parts of nervous system science, neuroscience, neurodegenerative issues, and neurosurgery and can change the field later on. For the benefit of the Stroke 2022 council, we are satisfied to welcome you to join the forthcoming "11th International Conference on Neurodegenerative Disorders and Stroke" scheduled to be held during April 25, 2022 as Webinar where you can investigate in different field, track down an amazing organization to make praiseworthy results.

General Quiries:

Kindly contact Program Manager, Cristina Grace by means of

Email: stroke@pulsusevents.net

WhatsApp: +44 20 80400181

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

Sessions and Tracks

Session 01: Neurodegenerative Disorders

Neurodegeneration is the progressive loss of structure or function of neurons, including death of neurons. Many neurodegenerative diseases – including amyotrophic lateral sclerosis, Parkinson's, Alzheimer's, and Huntington's – occur as a result of neurodegenerative processes. Such diseases are incurable, resulting in progressive degeneration and/or death of neuron cells. Many neurodegenerative diseases are caused by genetic mutations, most of which are located in completely unrelated genes. Neurodegeneration can be found in many different levels of neuronal circuitry ranging from molecular to systemic.

SUB-TRACKS

Cause and Symptoms
Ischemic Stroke
Haemorrhagic Stroke
Transient Ischemic Stroke
Diagnosis and awareness on Stroke

Session 02: Neuroscience

The study of nervous system that deals with physiology, anatomy, molecular biology of neuron and neural networks is called neuroscience. Neuroscience is also called neurobiology. The homo sapiens brain contains around one hundred billion neurons and one hundred trillion synapses, it consists of thousands of distinguishable sub-structures, connected to each other in synaptic networks. The majority of the approximately 20,000–25,000 genes belonging to the human genome are expressed specifically in axons; axons is used to transmit electric signals from one to one another which is connected with the help of synapses. The other set are called dendrites is to receive the information which is transmitted by the axons.

SUB-TRACKS

Molecular and cellular neuroscience
Neural circuits and systems
Cognitive and behavioral neuroscience
Computational neuroscience
Neuroscience and medicine

Session 03: Neurological Disorders

Neurological disorders are a type of disorders which means structural, biochemical and electrical abnormalities of brain, spinal cord or nerves in the nervous system. With the help of Neurology and Clinical Neuropsychology, these disorders can be studied and treated after neurological examination. There are two main broadest division called central nervous system disorders and Peripheral nervous system Disorders. The common symptoms of neurological disorders are paralysis, muscle weakness, poor coordination, loss of sensation, Seizures, Confusion, pain and altered levels of consciousness.

SUB-TRACKS

Brain disorder
Spinal cord disorders
Peripheral neuropathy
Trigeminal neuralgia
Autonomic nervous system disorders
Seizure disorders
Movement disorders
Sleep disorder

Session 04: Cerebrovascular Disease

Cerebrovascular is comprised of two sections – "cerebro" which alludes to the huge piece of the cerebrum, and "vascular" which implies supply routes and veins. Together, the word cerebrovascular alludes to blood stream in the mind. The term cerebrovascular sickness remembers all issues for which a space of the mind is for a brief time or for all time influenced by ischemia or draining and at least one of the cerebral veins are engaged with the neurotic interaction. Cerebrovascular illness incorporates stroke, carotid stenosis, vertebral stenosis and intracranial stenosis, aneurysms, and vascular abnormalities.

SUB-TRACKS

Congenital cerebrovascular diseases
Atherosclerosis
Embolism,
Aneurysms
Arterial dissections
Hypertension
Addiction
Moyamoya disease
Obesity

Session 05: Alzheimer’s Disease

Alzheimer's is the most widely recognized type of dementia, an overall term for cognitive decline and other intellectual capacities adequately genuine to meddle with day to day existence. Alzheimer's illness represents 60 to 80 percent of dementia cases. Alzheimer's is the most well-known type of dementia, an overall term for cognitive decline and other intellectual capacities sufficiently genuine to meddle with day to day existence. Alzheimer's sickness represents 60 to 80 percent of dementia cases. Alzheimer's is certainly not an ordinary piece of maturing.

SUB-TRACKS

Risk Factors of alzheimers
Diagnosis of alzheimers
Treatments of alzheimers
Clinical Studies of alzheimers
Alzheimer’s disease Pathophysiology and Disease Mechanisms

Session 06: Parkinson Disease

Parkinson's sickness (PD) is a constant and reformist infection of sensory system that have side effects which proceed and turn out to be more regrettable after some time. It is the second commonest neurodegenerative illness after Alzheimer's sickness, and in the UK, has a lifetime pervasiveness of somewhere in the range of 0.1 and 0.3% of the populace. The fundamental purpose for this condition is breakdown and passing of essential nerve cells in cerebrum. In ordinary conditions nerve cells present in the cerebrum creates a synapse considered dopamine that is liable for flagging development, feelings and co-appointment however on account of ailing individual dopamine creation dials back, thus the individual become unfit to control the development regularly. There is no fix except for treatment includes drug and medical procedure. Gradualness of deliberate developments, decreased facial appearance, dreary tongue, and reduced eye blazing, a rearranging walk with denied arm swing and bended stance, Shaky strength; trouble ascending from a sitting position, Swallowing issues in later stages.

Session 07: Huntington’s disease

Huntington's sickness is acquired from Parents and frequently side effects will be more similar to Parkinson's infection which incorporate issue with state of mind, mental capacities, Swallowing, Speaking, Sleep Disturbances followed by loss of co-appointment and precarious walk. A quality called HTT(Huntingtin) which is answerable for coding protein Huntingtin, if any transformation to that quality it will cause unsettling influences in the mind and results in death of synapse and prompts Huntington's infection. Anomalies with the freak huntingtin incorporate Cardiac Failure, Weight Loss, Osteoporosis, diminished glucose level. This condition is ordinarily seen in the people under the period of fifties.

Session 08: Neurotherapy

Neurotherapy is the Kind of treatment for neurodegenerative disorders. The philosophy behind neurotherapy involves activating or deactivating to the organ(s), through pressure or massage on the nerve channels to stimulate or depress the blood, & other body fluids and the nerve currents. The therapy focuses at the cause not at the symptoms of the disease. This method has no side effects and no instruments get involved in this treatment.

Mentally retarded child, Paralysis, Joint Pain, Chronic constipation, tail bone pain, Depression, Vertigo, Piles, Obesity, Hypothyroid, Insomnia, Anal fistula, Cramps, Diabetes, Cervical spondylitis, Arthritis, Angina pectoris, Menses related problem, Tennis elbow, Swelling, hair falling, Tilt, Allergy, Gastric problem, Motor neuron disease. These are the diseases which is successfully treated by neurotherapy.

SUB-TRACKS

Ayurvedic treatment
Inhibition of Cholinesterase Activity
Computational Approaches
Unani Treatment
Homeopathy treatment

Session 09: Etiology of Stroke and Risk Factors

A stroke is developed when the blood supply to part of your brain is interrupted or blocked, depriving brain tissue of oxygen and nutrients. Within minutes, brain cells begin to die. A stroke may be caused by a blocked artery (ischemic stroke) or the leaking or bursting of a blood vessel . Many factors can increase your stroke risk.. Potentially treatable stroke risk factors include: Being overweight or obese, Physical inactivity, Heavy or binge drinking and cigarette smoking or exposure to second hand smoke, High cholesterol, and Diabetes.

SUB-TRACKS

Brain Neurosurgery
Spine Neurosurgery
Cerebrovascular Surgery
Advanced Operative Techniques in Neurosurgery
Traumatic Neurosurgery
Neurosurgical Care

Session 10: Preventive Stroke Strategies

Many stroke prevention strategies are the same as strategies to prevent heart disease. In general, healthy lifestyle recommendations include: Controlling high blood pressure (hypertension), Lowering the amount of cholesterol and saturated fat in your diet, Quitting tobacco use, Controlling diabetes, Maintaining a healthy weight, Eating a diet rich in fruits and vegetables, Exercising regularly, Drinking alcohol in moderation, if at all, Treating obstructive sleep apnea, Avoiding illegal drugs.

SUB-TRACKS

Acute Management
Medication Treatment with Alteplase IV r-tPA
Mechanical Treatment to Physically Remove the Clot
Fibrinolytic Therapy
Cerebral Edema Control
Anticoagulation & Prophylaxis
Neuroprotective Agents

Session 11: Neonatal Congenital Effects

Structural abnormalities are the most common type of congenital defects that exists in an infant even before birth and is known as birth defect. Teratogen causes anomaly in infants and some disorders can be detected through prenatal screening. Most of the defects caused due to inheritance are mostly rare.

SUB-TRACKS

Congenital Disorders
Genetic Syndromes
Neonatal Jaundice
Teratogen

Session 12: Stroke and Mental Health

A stroke is an emergency of medical aspect that requires early treatment that indicates early action can minimize brain damage and potential complications. Person affected by stroke addresses cognition and/or behavioral problems that includes problems using languages, vision and perception problems and sudden bursts of emotions.

SUB-TRACKS

Stroke Types
Mental Health Care
Mental Health Counselling
Mental Illness & Treatment
Mental Health & Rehabilitation
Stress Management Programs
Assessment of Mental & Behavioral Disorders
Mental Health Nursing Practice
Mental health on Sports

Session 13: Dementia

Dementia is a syndrome characterized by cognitive or memory impairments that describes the symptoms of many conditions that affects the brain. The commonly seen conditions are Alzheimer’s and Parkinson’s disease. Symptoms seen at early stages are memory loss, personality changes, withdrawal and confusion.

SUB-TRACKS

Neurocognitive Disorders
Dementia with Lewy bodies
Mixed Dementia
Vascular Dementia
Frontotemporal Dementia
Need for awareness on dementia

Session 14: Vascular and Brain Imaging

Vascular imaging is a key component in the brain comprehensive stroke diagnosis and cause based therapy. Siemens supports with the full spectrum of angiography systems available today. Siemens analysis tools reduce the information load by removing distracting visual input (e.g. skull base) in intra-arterial (X-ray), CT, MR, and US angiography. Consequently, it assists in focusing on vascular changes and interventional procedures such as clot removal, thrombolysis and stent implantation. Tools for imaging of brain function includes Magnetic resonance spectroscopy, Single photon emission computed tomography, Functional magnetic resonance imaging (fMRI), Magnetoencephalography (MEG).

SUBTRACKS

Computed Tomography Scan
Electroencephalogram
Magnetic Resonance Imaging
Electromyography
Positron Emission tomography
Spinal Tap
Neurosonography

Session 15: Hemorrhagic Stroke

Hemorrhagic stroke involves bleeding within the brain, which damages nearby brain tissue and there are two types of hemorrhagic stroke: intracranial hemorrhage (ICH), which occurs with bleeding into the brain tissue and subarachnoid hemorrhage (SAH), which occurs with bleeding into the subarachnoid space beneath the arachnoid mater of the meninges. Causes of hemorrhagic stroke include Aneurysms, arteriovenous malformation (AVM), and Cerebral amyloid angiopathy.

SUB-TRACKS

Cognitive Behavioral Therapy (CBT)
Theories of Behavioral Science
Cross-cultural Psychology & Behavioral genetics
Behavioral Problems in Children & Adults
Critically evaluated Empirical research

Session 16: Stroke Rehabilitation and Recovery

Stroke is one of the main leading causes of long term adult disability which is affecting approximately 795,000 people each year in the USA. Someone who suffered a stroke can improve functions and sometimes remarkable recoveries by early recovery and rehabilitation. The goal of a stroke rehabilitation program is to help you relearn skills which are lost when stroke affected part of your brain. Stroke rehabilitation can help to regain independence and improve the quality of life.

SUB-TRACKS

Stroke Risk Assessment Tool (SRAT)
The Cincinnati Prehospital Stroke Scale
The Los Angeles Prehospital Stroke Screen
The National Institutes of Health Stroke Scale (NIHSS)
Anticoagulant and Antiplatelet Agents
Blood Pressure Control
Manage exercise and diet

Session 17: Pediatrics: Stroke and Metabolic Disorders

Stroke is more common in boys than girls even after controlling for differences in frequency of causes trauma and these appears to be a predominance of stroke in black children. This difference remains true even after accounting for sickle cell disease patients with stroke and moreover seizures are common in both ischemic and hemorrhagic strokes. They occur in up to 50% of children with strokes are not restricted to any age group and are not limited to any specific seizure type. A stroke or cerebral vascular accident (CVA) in children is typically considered to be a rare event. The reported incidence of combined and hemorrhagic ischemic pediatric stroke ranges from 1.2 to 13 cases per 100,000 children under 18 years of age.

Non-contrast head computed tomography (CT) is sensitive for acute bleeding and should be obtained emergently to exclude a cause for hemorrhagic stroke. Despite increasingly advanced imaging techniques the adult literature suggests that a lumbar puncture is still needed to rule out a subarachnoid hemorrhage.

SUB-TRACKS

Mental Health
Neurogenetic and Neurometabolic disorders
Addictive Disorders
Neurotoxicity
Myasthenia Gravis & Related Disorders
Neurocognitive changes in AIDS

Session 18: Pediatric Critical Care

Pediatric Critical Care is concerned with the diagnosis and management of life-threatening conditions that requires organ support and invasive monitoring. Critical care treatment raises issues that includes psychological health; pressure points; mobilisation and physiotherapy; and secondary infections. Critical care is provided to the children whose condition is potentially reversible and who have a good chance of surviving with intensive care support. A prime imperative for admission to an emergency unit is that the basic condition can be overcome. Convenient diagnosis and initiation of treatment are required in order to counteract unnecessary increases in patient morbidity and mortality.

SUB-TRACKS

Cardiovascular System
Central Nervous System
Endocrine System
Gastro-Intestinal Tract
Hematology
Renal System
Respiratory System

Session 19: Vascular Surgery and Neurosurgery

The Neurovascular surgery specializes in the management of complex central nervous system vascular disorders including arteriovenous malformations, aneurysms, cavernous angiomas and carotid and intracerebral stenosis. Surgery and vascular procedures can be used to prevent stroke to treat or to repair damaged blood vessels or malformations in and around the brain. Carotid endarterectomy is a surgical procedure in which a surgeon removes fatty deposits or plaque from the inside of one of the carotid arteries and this procedure is performed to prevent stroke.

SUB-TRACKS

Therapeutic targets & mechanism for treatment
Alzheimer’s disease symptoms
Rehabilitation Facilities
Skills & Techniques in Clinical training
Clinical Evaluation
Practices in Clinical training
Promoting Clinical Outcomes

Session 20: Current Breakthrough in Stroke Research

The randomized clinical research study shows a dramatic improvement in restoring blood back to the brain in arteries. This study involved minimally invasive clot procedure known as stent thrombectomy and this standard clot procedure called as tissue plasminogen activator. In patients with more severe strokes, each trail shows the striking benefit of catheter-based clot removal to restore blood flow in brain arteries. This can be used to improve the treatment for heart attacks known as acute stroke therapy. There is another new treatment for the stroke shown to be very effective that and it will be used as a part of standard stroke care.

SUB-TRACKS

Stroke rehabilitation: Care and guidance
Migraine & Chronic Pain
Neuropsychiatric Conditions
Neuropathic infections
Neuropathic pain in women’s
Functional electrical stimulation
Spinocerebellar ataxia
Neuropathy and therapies
Spinal muscular atrophy
Advanced neuropathic therapies
Neuropathic pain and its therapeutics

Session 21: Clinical Trials & Case Reports

Clinical trials and case reports includes the involvement of larger groups of people confirming the effectiveness of a drug or treatment, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely. This track gives researchers knowledge about new technologies, clinical trials and new aspects.

SUB-TRACKS

Prevention trials
Case Reports on Stroke
Advances in genetic research
Case Reports on Neurodegenerative Disorders
History of present illness in affected patients
Case Reports on Neuro Oncology
Coping with caring
Vaccination by self-antigens
History of present illness in affected patients

Market Analysis

SCOPE AND IMPORTANCE

Globally the market for stroke disorder & treatments increasing rapidly. The major factor that derives the growth of stroke disorder & treatment is the increasing high blood pressure patients. Ischemic stroke is caused by a dysfunction in the supply of blood to the brain due to emboli, thrombus or atherosclerosis occurring in cerebral arteries. According to a World Health Organization (WHO) estimate, around 17 million people die every year due to cardiovascular diseases. The statistics of the Centres for Disease Control and Prevention suggest that about 87% of all strokes are ischemic strokes. Moreover, stroke leads to 1 out of every 20 deaths, costing around $34 billion to U.S. annually. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The two major factors propelling the growth of the acute ischemic stroke diagnosis and treatment market are; large patient pools and a concerning rise in population at a higher risk of developing stroke in the near future. Rising incidence of diabetes along with heavy tobacco users and an increase in the ageing population are significant factors that determine the market growth.

New Product launches and collaborations are some of the key strategies adopted by leading industry players. In March, 2015, FDA approved WATCHMAN, a left atrial appendage closure device designed to prevent stroke in patients with atrial fibrillation. Silk Road Medical, Inc. has launched an Anti-Stroke Enroute Device, a transcarotid neuroprotection system, designed to access the common carotid artery through a minimally invasive technique. NeuroVive Pharmaceutical AB, entered into collaboration with BBB Therapeutics, for development of the NVP014 drug candidate used in the treatment of ischemic strokes.

COMPANIES

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Cordis Corporation
Koninklijke Philips N.V
GE Healthcare
Siemens AG
Stryker Corporation
Genentech, Inc. and Merck & Co., Inc.

Acute Ischemic Stroke Diagnosis and Treatment Market By Type

Diagnostics
- Computed Tomography (CT)
- Magnetic resonance imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
Therapeutics
Tissue Plasminogen Activator
Anticoagulant
Antiplatelet
Antihypertensive

Awards & Benefits

“Winning isn’t everything in life, it’s the only thing.”

Make memories and share your thoughts in this fantastic platform which is loaded with a bundle of opportunities and moments to capture

Awards-

Best poster Award
Young Scientist Award

Best poster benefits-

Unique opportunity to combine visual and oral explanations of your projects in the form of a poster presentation.
The entire accepted poster abstract will be published in reputed and supporting international journals with unique DOI given by CROSSREF.
Best posters will be given an opportunity to publish the full work at discounted processing charges in the supporting international journals

Young scientist benefits-

Advancing perfection and perceiving remarkable commitments made by the youthful researchers for their work done essentially during the span of study.
Find out about career advancement and the most recent research devices and technologies in your field.
Graduates are motivated by the chance to choose neighbourhood or worldwide subjects of pertinence/enthusiasm to them and build up their own logical examinations and models drawing in locally or universally.
Two researchers will be chosen for the Awards.
Chance to be a student envoy.
Chances to coordinate with partners around the world
Discounts at the PULSUS conferences, at different worldwide venues in the future.
Chance to distribute full-length papers in rumoured supporting international journals of respective conference
Best Young Scientist Award introduction will be named by the board and in the event that they wish to publish the full-length paper, they can publish in supporting worldwide journals of the respective conference at free of preparing charges.

Past Conference Report

With great support from our Organizing Committee, Pulsus Conferences successfully completed the "10^th International Conference on Neurodegenerative Disorders and Stroke" which was conducted in Rome, Italy from February 14-15, 2022 as a Virtual event.

First and foremost, we appreciate your faith in us and your participation in Stroke 2022, a worldwide conference focused on many aspects of Stroke, Neurology, and Neuroscience. There are several ways to express our gratitude to you for organizing a fantastic virtual gathering for Stroke 2022. We couldn't have done it without your continued support and faith in our organization, which has reached new heights in the field of Stroke, Neurology, and Neuroscience in order to attain Stroke 2022.

The meeting was marked by the participation of young and inventive scientists, industrial participants, and imaginative student groups from more than 20 countries, all of whom contributed to the success of this activity.

Various scientific and plenary meetings are used to hold the conference debates. The meeting began with an opening ceremony, which was followed by a series of talks by both Honourable Guests and respective Keynote Panel members. The experts who brought the subject to life via their superb presentation and testimonies from keynote speakers and seminars;

Catherine M Cahill | Harvard Medical School | USA
Radu Mutihac | University of Bucharest | Romania
David J. Dickoff | The Mount Sinai Hospital | USA
Sinerik Ayrapetyan| UNESCO Chair in Life Sciences Yerevan | Armenia

The event brought together diverse fields of Neurodegenerative Disorders with seminars and plenary talks by representatives from various universities and organizations

Jean Roch Alliez|CHP Clairval|France
Szu-Yi Chou | Taipei Medical University |Taiwan
DMD Noura Hasan | Mansoura University | Egypt
Felician Stancioiu | Bio-Forum Foundation | Romania
Sinjan Choudhary | University of Mumbai | India
Mai M. Abdelmoaty | University of Nebraska Medical Center | USA
Felipe Gomes de Barros Pontes | Federal University of Sao Paulo | Brazil
Ni Made Dwita Pratiwi | Sanglah National Public Hospital | Indonesia
Ishrat Jahan | Aligarh Muslim University | India

With the great response and feedback which we received at this event, Pulsus conferences are proud to announce our upcoming conference entitled "11^th International Conference on Neurodegenerative Disorders and Stroke" scheduled to be held on April 25, 2022 as Webinar.

We would like to see your pleasant participation, constructive engagement, and support in order to make this activity a success once more.

11^th International Conference on
Neurodegenerative Disorders and Stroke

Quick Links

Theme: Uprising the modern revolution for future research in Neurodegenerative disorders and Stroke

Conference Information

Welcome Message

Sessions and Tracks

Market Analysis

Awards & Benefits

Past Conference Report